Ten years experience with the first approved biosimilar recombinant human growth hormone drug in normal clinical practice

• Main Authors: Juan Pedro López-Siguero (Author), Margarida Palla García (Author), Elena Martínez Busto (Author), Francisco José Rebollo (Author), Manuel Pombo (Author)
• Formato: Libro
• Publicado: Elsevier, 2018-04-01T00:00:00Z.
• Subjects: article
• Acceso en liña: Connect to this object online.

Introduction: Recombinant human growth hormone (rhGH) is the first biosimilar drug approved by the European Medicines Agency in 2006, using the biosimilar registration process. It was authorised for the treatment of growth hormone deficiency, and growth disorders associated with Turner's syndro...